Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials

PURPOSE: The purpose of this meta-analysis was to compare the efficacy and safety profile of low-dose brexpiprazole (<2 mg/d) compared to placebo and standard-dose brexpiprazole (2–4 mg/d). PATIENTS AND METHODS: We identified relevant studies pertaining to the specific purpose of our meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mingjun, Qin, Bin, Mao, Yage, Wang, Hailing, Wang, Aiqin, Wang, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377399/
https://www.ncbi.nlm.nih.gov/pubmed/35979228
http://dx.doi.org/10.2147/NDT.S374577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377399/
https://www.ncbi.nlm.nih.gov/pubmed/35979228
http://dx.doi.org/10.2147/NDT.S374577

Ejemplares similares